HomeIDXX • NASDAQ
add
IDEXX Laboratories Inc
Nakaraang pagsara
$432.36
Sakop ng araw
$417.76 - $431.01
Sakop ng taon
$398.50 - $583.39
Market cap
34.23B USD
Average na Volume
578.90K
P/E ratio
40.33
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 975.54M | 6.56% |
Gastos sa pagpapatakbo | 230.65M | -15.42% |
Net na kita | 232.84M | 9.71% |
Net profit margin | 23.87 | 2.98% |
Kita sa bawat share | 2.80 | 10.67% |
EBITDA | 399.52M | 31.31% |
Aktuwal na % ng binabayarang buwis | 22.10% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 308.64M | -6.95% |
Kabuuang asset | 3.35B | 8.57% |
Kabuuang sagutin | 1.73B | -3.15% |
Kabuuang equity | 1.62B | — |
Natitirang share | 81.88M | — |
Presyo para makapag-book | 21.92 | — |
Return on assets | 27.00% | — |
Return on capital | 34.70% | — |
Cash Flow
Net change in cash
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 232.84M | 9.71% |
Cash mula sa mga operasyon | 220.08M | -19.22% |
Cash mula sa pag-invest | -27.37M | 1.69% |
Cash mula sa financing | -290.98M | -576.10% |
Net change in cash | -92.95M | -146.74% |
Malayang cash flow | 210.00M | 7.40% |
Tungkol
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. Wikipedia
CEO
Itinatag
Dis 19, 1983
Headquarters
Website
Mga Empleyado
11,000